Report Categories
View AllRecent Articles
View All
Relmada Therapeutics RLMD Stock Chart Relmada Therapeutics Inc posts 103 EPS miss vs estimates
Chicago REFI posts earnings beat with 54 surprise driving shares up nearly 3 in Thursday trading
Bullish BLSH Stock Overvalued vs Peers Slow Drop 20260416
Principal PFG Delivers Q1 2026 Beat EPS 207 vs 202 Expected
Maxeon MAXN Stock Consolidating at 076 Next Move Ahead 20260518
AI Isnt Underperforming Leadership Just Hasnt Caught Up Yet
Nouveau Monde Graphite NMG Holds Near Resistance as Graphite Sector Watches Key Levels
Beyond Acquires Buy Buy Baby Intellectual Property Reuniting Brand with Bed Bath Beyond
ATLCP Q1 2026 Earnings Preferred Stock EPS Surges Past Estimates with 2579 Beat
Retail Investors Gain Direct Access to SpaceX IPO via Major Brokerage Platforms
JHG Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions
enGene Holdings Q1 2026 Earnings Narrowed Loss Beats Estimates Shares Rise
STVN Q1 2026 Earnings EPS Beat on Tight Cost Control Shares React Positively
WLY Q1 2026 Earnings EPS Surpasses Estimates by 1167 Stock Responds Positively
AQST Q1 2026 Earnings Narrowing Losses with EPS Beat of Nearly 50
CPT Q1 2026 Earnings Strong EPS Beat as Operating Efficiency Lifts Results Though Stock Edges Lower
MTZ Q1 2026 Earnings Strong EPS Surprise Amid Mixed Market Reaction
Lantheus Q1 2026 Earnings EPS Beat of 1585 Amid Flat Revenue Disclosure
Tempest Therapeutics Q1 2026 Earnings WiderthanExpected Loss Amid PreRevenue Development Stage